Liu et al. found that phosphodiesterase 4B (PDE4B), a key enzyme modulator in immune and inflammation-related diseases, was significantly upregulated in the serum of AKI patients and participated in the progression of AKI (Liu et al., 2020). Here, PDE4B is linked to acute kidney injury.